ESC Premium Access

Revascularisation is primarily intended for chronic coronary syndrome patients with symptoms refractory to medical therapy: con.

Congress Session

About the speaker

Doctor David Holmes

Mayo Clinic, Rochester (United States of America)
1 presentation
0 follower

2 more presentations in this session

Revascularisation is primarily intended for chronic coronary syndrome patients with symptoms refractory to medical therapy: pro.

Speaker: Doctor R. Al-Lamee (London, GB)

Thumbnail

Great Debate: is revascularisation primarily intended for chronic coronary syndrome patients with symptoms refractory to medical therapy? – discussion.

Thumbnail

Access the full session

Great Debate: is revascularisation primarily intended for chronic coronary syndrome patients with symptoms refractory to medical therapy?

Speakers: Doctor D. Holmes, Doctor R. Al-Lamee
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

Beyond the ISCHEMIA paradigm: updating the role of stress tests, coronary CT and optimisation of medical therapy.

27 August 2021

ESC Premium Access

Coronary Arteries Aneurysms and Ectasia in a patient with STEMI: a tricky management.

27 August 2021

ESC Premium Access

Successful Transcatheter Occlusion of a Left Ventricular Outflow Tract Pseudoaneurysm Using a «Plug and Coil» Strategy.

27 August 2021

This platform is supported by

logo Novo Nordisk